Across England, the NHS has spent about £100 million providing private treatment for patients on waiting lists

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.634, 2011-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Treatment Outcomes for Persons on Waiting Lists

By Chun JongSerl Guydish Joseph Silber Ellen Gleghorn Alice

The American Journal of Drug and Alcohol Abuse, Vol. 34, Iss. 5, 2008-09 ,pp. : 526-533

Informa Healthcare

Access to resources Recommend Favorite

Is the NHS willing to help clinicians and patients reduce uncertainties about the effects of treatments?

By Chalmers Robert JG Jobling Ray Chalmers Iain

Clinical Medicine, Vol. 5, Iss. 3, 2005-05 ,pp. : 230-234

Royal College Of Physicians

Access to resources Recommend Favorite

Alitretinoin [Toctino; Basilea Pharmaceutica] has been accepted as a treatment for severe chronic hand eczema in Scotland's NHS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 574, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Waiting lists for HIV drugs swell as US economy weakens

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 607, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

£1.3 million will be spent by the UK government over the next 2 years

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 312, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite